派林生物：上半年净利润2.36亿元 同比下降27.89%

Core Insights - The company reported a revenue of 986 million yuan for the first half of 2025, representing a year-on-year decline of 13.18% [2] - The net profit for the same period was 236 million yuan, down 27.89% year-on-year [2] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase capital through reserves [2] Financial Performance - Revenue: 986 million yuan, down 13.18% year-on-year [2] - Net Profit: 236 million yuan, down 27.89% year-on-year [2] Dividend Policy - No cash dividends will be distributed [2] - No bonus shares will be issued [2] - No capital increase through reserves will occur [2]